The Manufacturing and Technology Integrated Campi SENAI CIMATEC started the activities in March of 2002. CIMATEC is one of the most advanced campus for education, technology, and innovation of industry in Brazil. This is a private non-profit institution supported by the Federation Industry of Bahia that was created to upgrade the"National Technical Learning for Industries Support". Recently, CIMATEC became a university campus with 33 engineering and computer science technological areas. In the present time, SENAI is supported by a staff of over 650 members to support the activities of professional and higher education, and a Technology Center, all encompassed in the same building structure.
SENAI CIMATEC School of Engineering initiated operations in 2004, and currently offers nine Undergraduate degrees courses in Engineering, and a series of Graduate programs, including lato sensu (specializations and MBAs) and stricto sensu (Master 's and Doctoral degrees). In 2008, the Industrial Management and Technology (GETEC) and the Computational Modeling and Industrial Technology (MCTI) Master's Programs were inaugurated. MCTI incorporated a Doctorate in 2010, and, GETEC also opened a Doctorate Program in 2016.
SENAI CIMATEC prides on delivering highly qualified professionals to the several industrial sectors, supporting innovation and problem-solution, having earned the recognition of Brazilian Ministry of Education as the top Engineering School in the North/Northeast Regions of Brazil in the last five years, and one of the most important institutions in innovation and knowledge in the country.
Even though CIMATEC activities are carried on in a decade, it is already recognized as one of the main Science and Technology Institutions of the country. The National Confederation of Industry of Brazil (CNI) has acknowledged publicly that SENAI CIMATEC is a reference in the implementation of the network of SENAI Innovation Institutes (ISI) and SENAI Technology Institutes (IST). ISIs are strong allies of the Brazilian industry in the development of products, processes and applied research. In our campus, there are three ISIs and six ISTs installed since 2014: the ISIs in Automation, Metal Forming, and Material Unions and Logistics, and the ISTs in Civil Construction, Chemistry, Electrical and Electronics, Food Technologies, Electromechanical, Environment, and Health.
SENAI CIMATEC runs projects of high national and international impact to support companies from different regions of Brazil with a strong performance in Research, Development, and Innovation (R&D&I). Although, it maintains a network of partners that include prominent universities and organizations from all over the world in the field of Software and Supercomputing; Mobility and Infrastructure; Metrology and Development of New Products and Materials; Robotics and Automated Systems; Energy and Sustainability; Advanced Manufacturing; Micro and Small Enterprises (MSE), Biotechnology, and Health.
In this scenario, SENAI CIMATEC created the Health Institute of Technology (ITS) in 2017 under the leadership of a national and international recognized scientist medical, Roberto Badaro, MD, PhD., to organizes the interfaces of the existing engineering technology of CIMATEC, to support the health industrial and economic complex in the development of drugs, medicines, equipment, and materials that are strategic for the public health system of Brazil (Brazilian Unified Health System -SUS). For that purpose, the Institute is working on research, development, innovation, regulation, publications, education and management of economic and welfare data. The Health Institute of Technology will develop cutting-edge technology to meet the demands of research, development, and innovation (R&D&I) projects in the area of Healthcare, Chemical and Biotechnology and Devices Applied to Health, which includes: Equipment and Materials for Health Use · Development of electromedical equipment; · Assistive technology development; · New materials applied to implants; · Integrated systems (software, microelectronics, and embedded electronics); · Data management software (Big Data and Telemedicine); · The E-Health; · The augmented reality and virtual with medical applications (IoT); · Robotic surgery; · Development of diagnostic kits. Quality, Regulation, and Management · Incorporation of technologies in SUS; · Economic regulation: the possibility of tax alteration; attracting foreign companies to Brazil from government incentives; certification and test of products; · Management of economic data, epidemiological, regulatory, and development of new technologies (clinical trials).
The biotechnology and innovation market grows exponentially in Latin America. With the new purpose of incorporating 4.0 concept into the area of healthcare, an enormous number of new scientific information in technologies applied to health are available. A new journal devoted to publishing this information would help to foster collaborations in these technologies that can be applied to the development of health tools among scientists in the world.
I n t h i s s e n s e , I T S / S E N A I C I M AT E C created The Journal of Bioengineering and Technology Applied to Health (JBTH) in order to open the opportunity to speed these collaborations. JBTH is a peer-review open access and multidisciplinary Journal with the aim to develop a platform for innovative researchers and scientists to explore the advanced and latest research developments in the field of Biomedical Engineering and related disciplines that are applied to the development of new tools for diagnostics and treatment in the area of healthcare.
JBTH will publish articles related to the most recent advancement discoveries and applications in the field of bioengineering, biotechnologies, Big Data, nanotechnologies, molecular engineering, biochips, medical electronics, medical devices and instrument guided surgeries, biomechanics, clinical engineering, genetic engineering, photonics, new therapeutic strategies including steam cell therapies, gene therapy, new molecular biology discoveries and any scientific reliable information on advanced and very latest research topics.
Infectious diseases have been one of the most significant public health problems in the world. Despite the diagnostic advances in medicine they still account for one in three deaths occurring worldwide [1] . In recent decades, technological progress has enabled the development of methods capable of detecting the antigen-antibody complex with high efficiency and reliability, through immunological techniques that reveal sensitivity to antigens (intradermal and percutaneous reactions), presence of antibodies or antigens in the body, (immunofluorescence, radioimmunoassay, enzymelinked immunosorbent assay, immunofluorimetry and chemiluminescence assays) [2] . Despite rapid tests, several immunodiagnostic tests still require specialized professionals to perform the procedures, an appropriate place for processing, specific materials and reagents and time for the determination of the results.
To create fast, cost-effective clinical diagnostic tests without the need for specialized professional, with little biological material, the Precision Photonics Corporation (PPC), in partnership with University of San Diego (UCSD), enhanced a biochip reader. This method was based in microarray-technology with an integrated circuit and photonic system for rapid and cost-effective diagnosis of numerous infectious diseases (PPC/ mBio Inc. -Biochip Reader). The Federal University of Bahia (UFBA), Brazil, joined this project to use this technique in the diagnosis of HIV, HCV, and related coinfections.
In this study, we present the results of Phase 2 of the project, with significant and promising results in the validation of biosensors for HIV and HCV. The Federal University of Bahia performed this Phase of the project in collaboration with Precision Photonics Corporation (PPC), mBio Diagnostic Inc., and the Division of Infectious Diseases of the University of San Diego (UCSD), California, USA, and the tests have been carried out in Brazil supported by Research Support Foundation of the State of Bahia (FAPESB).
Development of Biochip Readers/Biosensors (Biochip Reader)

Naval Research Laboratory (NRL)
The Multi-Analyte Array Biosensor (MAAB) was developed by the Naval Research Laboratory (NRL) of Washington (DC), USA, to detect and identify multiple analytes simultaneously [3] . The Biochip Reader is an electronic instrument developed for the detection of nanograms of toxins, allergens, proteins, bacteria, parasites or antibodies and antigens, using a minimal amount of biological material, without the need for specific processes [4, 5] .
The NRL biosensor was designed using the microarray system and to be used with a laptop for fluid control, data analysis and storage [6] . Due to their selectivity and sensitivity, immunoassays were the first choice for the development of rapid identification methods using the fluorescencebased RL array biosensor [3] .
Precision Photonics Corporation
Precision Photonics Corporation (PPC), USA, proposed a research and development program aimed at low-cost technology for the diagnosis of HIV and related coinfections. Due to the global nature of the disease and diagnostic products on the market, it was necessary to qualify the development tool outside the United States to assess its performance in a population with different conditions. Therefore, PPC and the corporate division of mBio Diagnostic adapted the biosensor of NRL arrangements and successfully developed prototypes of a low-cost diagnostic tool for infectious diseases. A biochip (consumer disposable) -containing the analytic for recognition; the transducer (non-disposable); and the reader (non-disposable) are the basement of this equipment ( Figure 1 ).
Development of the Biosensor by PPC
The biochip's PPC reader is a fluorescencebased laser optical detection system and uses a laser diode, and a CMOS or CCD toner comprised the source and the detector. The equipment consists of a laptop, a multi-pathogens biosensor (reader) to detect analytes at one time, a separate interface to avoid contamination (Figure 2a -details in Figure  3 ) and the 'slides' in the form of microarray strips, previously sensitized ( Figure 2b ). It is simple, portable, easy-to-operate equipment that requires minimal sample preparation and low-power handling, and it is appropriate for use in rural areas and districts with poor socioeconomic conditions.
Methods of Biochips Units (Diagnostic Cards)
The biochip (diagnostic card) is a miniaturized plastic strip, arranged in microarrays, with the presence of negative and positive controls and sensitized with the antigens of HIV and HCV. The preparation of these strips specifically for these target pathogens occurred in Phase 1 in the United States.
Preparation of Biochips to Phase II
The samples were placed in closed containers and pumped directly into the chips at Precision Photonics Corporation (PPC), USA. Thus, the chips (slide/trips) ( Figure 2b ) presented specific areas containing concentrations of antigens by enzymelinked immunoassays, such as the indirect ELISA technique. Subsequently, each pathogen was identified electronically and placed within a particular location where the pumping of the sample was directed (Biodot-Arrayer). In this stage of construction, doseresponse curves were prepared for each pathogen to compare the results obtained in Phase I.
The Study
The Laboratory of Tropical Diseases of the University Complex Prof. Edgard Santos (HUPES) at the Federal University of Bahia (UFBA) conducted this study. It consisted of the evaluation and application of the material sent by PPC / mBio, which include: strips/slides already previously sensitized and blocked in the USA (Biochip Reader with BCRanalysis software and runcamera.exe installed on a laptop), protocols 1 and 2; using the samples (sera/plasma) collected and data provided from HUPES patients as well as materials and reagents.
We selected 65 sera/plasma from patients positive and negative for HIV, HCV, and HTLV and related coinfection. We chose randomly 52 old sera from the Tropical Diseases Laboratory, following protocol 1 ( Figure 4 ); and 13 (7 sera and 6 plasma) during protocol 2 ( Figure 5 ). Figure  4 ) showed antigens for the HCV core and HIV gp41 protein viral envelope. Protocol 2 ( Figure 5 ), in addition to the antigens referred to in the previous protocol, the antigens of the HIV gp120 proteins, HCV NS3, and the reduction of a spots grid for both positive and negative control were inserted, and the protocol included a large number of spots for human IgG control. Besides, spots containing HIV gp41 antigen were enlarged.
Regarding the reagents and procedures adopted, the two protocols were identical.
The protocols provided the procedures: (1) strip washing and new blocking; (2) incubation with the human serum samples; (3) incubation with labeled antibody; (4) rinsing, drying and image detection on the reader (Biochip Reader). We obtained human serum samples with HIV / HCV (+/-), (-/+) and (-/-) from the serum bank of the Tropical Medicine Laboratory at the Federal University of Bahia. The blocking buffer used was commercial Pierce buffer, mixed in the ratio of 1:1 with the Tris-EDTA buffer. Detection of the labeled antibody used was anti-human IgG Alexa 647 (Invitrogen / Molecular Probes).
Data Analysis and Determination of Exposure Time
BCRanalysis performed the Data analysis by the software of the Biochip Reader, which analyzed the image-points with specific programming. This programme probes the intensities of the spots for HIV and HCV were relative to the positive and negative controls in the same slide. PPC/mBio defined the cut-off in the procedures forwarded to designate the positive or negative result, using the pre-programming of <255 ms, without the use of background subtraction and images with 1280x1024 pixels.
HIV/HCV Sensitized Slides
Patients' sera were identified according to positivity or negativity alone or with coinfection, as described in Table 1 . Table 1 . Tested samples of HIV, HCV, HTLV negative and positive patients and coinfection related. The results obtained showed sensitivity and specificity of 100% when correlated with previously known results from the serum file of HUPES, which used the ELISA method. In all HTLV positive patients tested, there was no cross-reaction or interference noise in areas sensitized with HIV and HCV specific antigens and controls ( Figure 6 ). The slides 1and 5 were not blocked during protocol as determined by the procedure; however, this did not change the final results. In the remaining 47 samples, protocol 1 followed regularly, and the result was consistent with the results previously known to the patients (Figures 7 to 10).
Slides Patients (N=65) /Infection HIV+ HIV-HCV+ HCV-Total
Evaluation of Protocols
PPC/mBio submitted 38 slides for testing following the protocol 2. Table 2 summarizes the events with this material.
Thus, of the 38 slides sent, only 13 slides were tested according to the second protocol, which was also compatible with ELISA results, performed shortly after collection from the patients. The lack of blockade in 5 slides during the application of protocol 2 also did not affect the final results ( Figures 11a, 11b , 11c -the same patient -and 12a, 12b -other patients). Figures 13 to 16 present the results of 13 slides tested according to protocol 2. Statistical Analysis Data analysis was performed by BCRanalysis, the software of the Biochip Reader, which analyzed the image points with pre-specific programming by PPC/mBio, and SPSS Software to calculate median, mean and mode.
Time of Exposure (protocol 2)
Tests with the exposure time of 50 ms obtained the best results (Table 3) , this being the time of exposure most indicated during this experiment. The advances in miniaturization allowed the development of portable systems, electronic and digital components. This development enabled the discovery of the microarray system with the power of simultaneous analysis of thousands of molecules at the same time [3, 8] , and the improvement of the biosensor. In this study, we describe a Biochip Reader platform for diagnosis that provides a single-sample marker analysis at the same time. The method consists of using a disposable cutting slide integrated with a fluorescence reader based on planar and multimode wave conductors capable of analyzing different tests for detection of specific antibodies (HIV/HCV) at the same time. The sensitivity and specificity were of 100%, without cross-reaction with other known pathogens (HTLV and cytomegalovirus). The tests revealed the ability of the system to maintain the antigen/antibody reaction specific to the researched condition. We also analyzed all the technical steps and procedures, manuals and protocols sent by PPC/mBio to obtain the results.
The results showed the excellent reliability of the system. However, the poor quality of the slide manufactured in the USA may have interfered and affected the experiment carried out in Bahia (UFBA) due to the presence of weak signals, backgrounds in slides or no sharp image in the signal emission, which possibly did not allow good antigen-antibody binding and the action of the fluorophore.
This study emphasized the importance of the quality of the material to be chosen as a substrate for the bioreactor, such as the polishing of the slides [15] [16] . Battison (2001) [17] and Vo-Dihn (1998; 2000) [18, 19] described that substrate polishing is fundamental for good wave conduction and signal emission. As a result, in our study, the poor quality of the slide due to poor polishing of the glass might have impaired and prevented the conduction of the evanescent wave adequately, which was decisive for the presentation of the weak controls, the presence of background and low signal of the antigens for HCV during the use of protocol 2. So, the polishing problems may be related to the imprinting (PPC), causing "dragging" of the molecules during the washing process and subsequently protocol procedures [20] .
Also, Monk (2004) [20] and Grace (2011) [16] affirm that for optical systems that use planar wave conductors, they must have their substrate properly polished otherwise they will be unable to conduct the wave and create random or inappropriate signals. According to Feldstein (1999) [21] , a fluorescence biosensor, based on planar wave conductors, will work correctly, if the surface of the biochip base (glass, silica or other suitable material) is appropriately polished. This condition may be one of the factors that left all the weak positive controls in the first position, according to protocol 2.
Another problem was the fungus contamination that could occur due to the quality of the slides, transport, and excessive humidity present in our environment or inadequate storage. However, according to Vo-Dihn (2000) [22] and Rowe (2011) [23] biosensors should not have many specifications regarding storage and handling, since the intention is to create a portable and easy handle system.
The slides showed crystal formation and an excess of trehalose, which may be caused by the high temperatures in Brazil [24] , which brings the importance of choosing the substrate for the printing of biochips, polishing and pre-blocking with appropriate washes so as not to permit the residue of sugars, which could interfere in the results (backgrounds, inability to signal and read) [7, 25] .
Notwithstanding, the extremely positive point is that, despite the occurrences in the signals, there was a sensitivity of 100% in the samples analyzed. Besides, the sera used during the procedures of protocol 1 were old, and this does not seem to change the results. Plasma and serum were also used during the process with protocol 2, and there was no evidence of any change in the results obtained compared to the results using the ELISA method performed concomitantly during this experiment.
The use of two protocols for the tests performed in Bahia occurred due to the emission of more stronger signals in the HIV go 41 region, presenting a "ballooning" of the area for HIV gp41 during the experiment with protocol 1 (Figures 4, 9 and 10). This phenomenon raises doubts as to the right binding in the biomolecules adhered to the spots, because of the overflow which occurred and the bond could occur outside the space previously printed, emitting stronger signals (>255 ms), impairing the reading of the slides [26] . This event occurred due to the size of the protein, but it was adjusted in the second protocol to remain no doubt about the results.
The pre-blocking and printing on biomolecule integrated circuits are punctual phases for biochip formation according to Lochhead (2008) [26] , Grace (2011) [16] and Macbeath (2000) [27] . Our results showed an excellent pre-blocking performed by PPC/mBio, since the changes made in the procedures, without the buffering of the slides, did not cause differences in the final result.
The time of exposure is one of the determining factors for the knowledge of sensitivity and specificity in multi-strand-based optical biosensor tests since the amount of ms is fundamental to the reliability of the experiments [26] . Sometimes it is difficult in normalizing the signal of one strand with the sign of another strand in the biosensors due to the differences between optical fibers. This issue is related to the variation of the exposure time to which each fiber is submitted [25, 28, 29] . As each antibody has a specific intrinsic fluorescence, the fluorophores are inserted to stabilize the signal during the analysis [16, 30] . However, if the exposure time is not "normalized," or preprogrammed on the optical substrate, there will be no stability about exposure time, and this could lead to significant variations in the readings for the same bioreactor [11, 12, 28, 29, 31] .
So, the time of exposure time was also a critical factor observed in the experiment, since the tests performed with protocol 2 were well below the 255 ms stipulated as a cut-off for reading. During the tests with protocol 2, the best exposure time was 50 ms, without the use of background subtraction and images with 1280x1024 pixels.
The results obtained for the exposure time also could be related to the limitation of mass transfer instead of a fluorescence transduction signal. The mass transfer has long been recognized as a limitation in this type of microarray system [30, 31] , which may have led to signal weakening, poor readability, or low exposure time for microarrays in the performance of protocol 2.
Furthermore, data analysis showed that each antigen would require tests at different concentrations in the same blocker and patient serum samples and their dilutions to precisely determine which antigen, blocker, and dilution concentrations of serum samples the experiment should have. It will allow better sensitivity and specificity detection in this multi-analyte format.
Phase II of the study showed good sensitivity and specificity of the system despite the problems presented. More experiments and further improvements are necessary for multi-pathogen detection, which is fast, cost-effective and does not require professional ability to handle the system.
The experiments performed in Brazil showed satisfactory results regarding the performance of the integrated circuit reader system (Biochip Reader) (the PPC/mBio Inc.) in the diagnosis for antibodies against HIV and HCV, with a sensitivity and specificity of 100%. Nevertheless, adjustments are still necessary to make PPC/mBio's Biochip Reader an efficient, low-cost, portable and easy-to-handle tool. These improvements include larger sampling volume, technical development (slides/trips), optimization of protocols, and standardization of exposure time without large intervals.
Future Perspectives
The University of San Diego and PPC m/Bio updated the model as a result of the tests carried out in Brazil. This new prototype has more resistant tools; technical improvement of the biosensor, bioreactors, and biochip; and innovative design of slides; better polishing of antigen-specific fixation areas; new lens models and optical filters; fluid channel system more suitable for mass transfer; panel expansion of controls; and a new protocol. Also, the software was adequate and easy to use and handle, with a higher degree of automation and less possibility of manipulation by the user (Figure 17 ).
PPC and m/Bio sent the new prototype to Brazil (Figure 18 ) with the original slides, protocols and faster procedures for validation of tests for HIV, HCV, HBV, T. pallidum and T. gondii. The activities are in progress, and promising results would be obtained for the final stage of the validation of the tests. Computational Fluid Dynamics (CFD) is a set of numerical methods that obtain solutions to problems involving physical and chemical phenomena of fluid dynamics and heat transfer [1] .
CFD has applied only in high technology engineering a few decades ago [2] . However, its use has now expanded to other applications, such as petrochemicals, automotive, aerospace, and medical industries.
The medical field has shown increasing interest in computer simulations because of the ability to reproduce the effects that influence medical diagnoses [3] . There are many advantages of using CFD in the area of health. It is a non-invasive method for research in biological systems, reducing the risks involved in a procedure. Also, it is faster and involves lower costs when compared to experimental and theoretical methods [4, 5] .
Computational Fluid Dynamics has been applied in different fields of research in several medical areas. Augusto (2014) [6] studied air flow and particle deposition in the pulmonary airways using CFD (Figure 1) . Similarly, Kim and colleagues (2013) [7] used the method to simulate airflow inside the nasal cavity. CFD has also been used for the development of medical devices and endoprosthesis. Feurhuberand colleagues [8] used the statistical approach of CFD for steam sterilization tests. The results concluded that the model developed by CFD can predict properties, such as temperature, steam quality; and also the visualization and understanding of the sterilization procedure.
Another significant area is the computational analysis of blood flow. The application of CFD in hemodynamics has featured in several studies, especially those related to cardiovascular diseases, such as atherosclerosis and aneurysms.
Lima and colleagues (2015) [5] and Blessy and colleagues (2016) [9] presented studies that reviewed the application of numerical methods and computational simulations in hemodynamics. The present work aims to demonstrate the relevance of CFD applied to hemodynamics in atherosclerosis through a brief literature review.
Computational Fluid Dynamics
Fluid dynamics is based in Navier-Stokes equations, which is conduct by the mass conservation and momentum (Equations -(1) -(3)]. p = pressure; t = time; x, y, z = Cartesian directions; u, v and w = velocities in x, y, z directions (three-dimensional velocity vector); μ = viscosity of the fluid; S MX , S MY , S MZ = transitory terms in the directions described.
The difficulty in solving the conservation equations analytically for turbulent flow and complex geometry applications requires the application of numerical solutions.
There are 3 different streams of numerical solutions techniques: finite difference, finite element, and spectral methods. The method of finite volume method is central to the most well-established codes, such as CFX/ANSYS, FLUENT, PHOENICS and STAR-CD [10] .
Despite using numerical models, the approach of the turbulence phenomena requires the application of turbulence models to reduce computational time. References and theoretic indications frequently used turbulence models ( Table 1 ).
The Use of CFD in Hemodynamics
Hemodynamics is the study of blood circulation through blood vessels, arteries, veins and capillaries that make up the cardiovascular system [11] . Mathematical models proposed by CFD can simulate the cardiovascular system [12] . The study of CFD in hemodynamics can help to understand what occurs during blood flow. As a result, it could aid in the diagnosis and prevention of cardiovascular diseases; the identification of Table 1 . Models of turbulence. hemodynamic properties; the analysis of advanced diseases; surgical procedure and the development of medical devices.
The application of CFD is based on the following 7 steps: clinical imaging, segmentation and reconstruction, discretization, contour conditions, simulation, post-processing and validation [13] .
Medical images provide anatomical and physiological details, which are obtained from ultrasound, computed tomography and magnetic resonance imaging [13] . The conversion of clinical images into geometric models is the base of the segmentation and reconstruction' stages.
Discretization is the production and refinement of the computational mesh that divides the geometry into volumetric cells. The limit conditions are the physical conditions for the entry, exit, and walls of the model, and the initial parameters and properties of the fluids used.
Computer simulation of cardiovascular system in 3D consumes time and computational demand. Post-processing is done, such as graphs and tables for analysis, to extract the relevant data. After that, the results obtained are analyzed and compared with existing parameters in medicine for validation [13] .
An important hemodynamic factor is the viscosity of blood flow. The blood's viscosity can vary according to the applied shear stress. If the strain rate is higher than 100 s-1, which happens in the large arteries, the blood behaves as a Newtonian fluid (constant viscosity). However, if the rate is lower than 100 s-1, the viscosity will present non-Newtonian behavior (variable viscosity) which occurs in the small arteries [14, 15] .
There are some models for representing the non-Newtonian behavior of blood flow, such as the Casson model, the Carreau model and the Power Law model [12] . A comparison of the viscosity of these models is shown in Figure 2 [12] .
The Use of CFD in Atherosclerosis
Heart disease is the leading cause of death in the world [19] , and atherosclerosis will become the primary source of this disease by 2020 [20] .
Atherosclerosis is the result of the deposition and accumulation of fatty-rich and inflammatory substances that accumulate on vessels walls and form atherosclerotic plaques. These events limit the blood flow, causing a narrowing and hardening of the vessels, causing an inadequate supply to vital organs (Figure 4 ) [21] [22] [23] .
Atherosclerosis affects regions of complex hemodynamics, such as arterial bifurcations, usually in areas of low shear stress [24] . The shear stress in the vessel walls is one of several Tabacow (2014) [16] used CFD in a study of cardiovascular diseases, in which the influence of endoprosthesis on aneurysms through a computational analysis of circulation of blood was analyzed. This result was able to justify the implantation of an endoprosthesis in patients to reduce the degradation of the vessel.
Azevedo (2010) [17] , as well as Shishir and colleagues (2015), studied hemodynamic properties in models of saccular aneurysms to understand the pathology (Figure 3) . hemodynamic factors that are related to the development of the disease [25] . Therefore the identification of these factors could enable early detection and prevention of atherosclerosis [26] , as well as help in assessing the severity of stenosis [23] .
Computational simulations of atherosclerosis can help in the determination and analysis of these factors, collaborating with the treatment and prevention of the disease. Figure 5 shows the shear stress in the artery with atherosclerosis, showing a tension peak in the existing damage point.
The CFD method has contributed to the therapeutic and surgical planning of the most various cardiovascular diseases [27] . It could also collaborate in the surgical procedures by predicting the results of stenosis. The study developed by Polanzyck and colleagues (2018) [28] is a comparison of before and after surgeries of stenosis through computational simulations and medical examinations. It was possible to use CFD to assist in predicting the outcome of critical stenosis surgeries with a 90%-98% accuracy in results [28] .
Furthermore, several studies are using CFD for medical devices that aid in the treatment and procedure of atherosclerosis [29] [30] [31] [32] . Figure 6 shows the results of the variation in shear stress with a stent implanted in the artery. There has also been research into the development of equipment, such as the analysis developed by Dehlahi and colleagues (2008) [33] , which compares the properties of different stent models.
Future Perspectives
According to Lima and colleagues [5] , the implementation of computational methods combined with conventional methods will enable the development of predictive medicine, such as the choice of appropriate surgery based on the comparison between results of computational surgeries performed. Furthermore, the mapping of the physiological properties of atherosclerosis hemodynamics should be done for prevention and diagnosis, as well as the development of technologies and devices for treatments and procedures in the disease.
Conclusions
Computational Fluid Dynamics can contribute to advances in medicine, especially in the study and analysis of hemodynamics applied to cardiovascular diseases.
However, more studies are needed with CFD applied to medicine to apply this method for other diseases, using new fields of Engineering in Medicine. According to the World Health Organization (WHO), the health products sector comprises more than 10 thousand categories of products and about 1.5 million different items. This broad range of products varies from low levels of technological intensity and high technological complexity.
Acknowledgments
SENAI CIMATEC University
The health care industry is one of the most dynamic sectors of the world economy, with an estimated annual turnover of $ 350 billion in 2014, with about 30,000 industries around the world, and more than 1 million employees. Brazil is the 7th largest market in the world, accounting for about 5% of the country's total health expenditure and earning about the US $ 11.7 billion in 2014 [1] . It is a future-bearing industry, as it is a source generating innovations incorporating technological advances in addition to the dynamic interrelations in the scope of IHC and the economy sector [2] .
In the public sphere, the Ministry of Health promotes the MAE and OPSM's market for the acquisition of these technologies through transfers to public and private non-profit institutions, linked to the Unified Health System (SUS -Sistema Único de Saúde), as well as in the reimbursement of procedures that use these products for health.
Decentralization of public health management and resources is one of the guidelines of SUS. The procedure of the needs is upward, from the local to the federal level, following deliberative agencies and consistent with the requirements of the health programs and the budget available. As a result of the acquisition of health products predominantly occurs in a decentralized manner, where each agency is responsible for purchasing services, such as OPSM and MAE individually, using their bidding processes. Decentralized purchasing spreads available resources keeping track of the government purchasing power. On the other hand, the centralized acquisition process is difficult, because it requires the analysis of several technical and operational aspects, such as agreement among the subjects involved, planning, priorities, definitions of specifications and technical descriptions, technological design, cost analysis, acquisition, distribution/logistics, training, operation management, disposal and reverse logistics.
The Ministry of Health makes a constant effort to provide health units with the installation of new equipment. Most of this spending is on MAE, from the most straightforward needs of a Basic Health Unit (SUS) or Emergency Care Unit (ECU / UPA) to the most sophisticated for health units and hospitals of medium and high complexity.
Currently,the health care of the population requires the use of some of these technologies, despite the fact that the emphasis is still on primary care, such as the Family Health Care Program (FHCP / PSF) or the Basic Health Units (BHU / UBA), in which MAE of low complexity are contemplated and indispensable for clinical procedures. Thus, the use of these technologies is a valuable tool to provide efficient care to the patient [3] .
The main aim of this study presents an review study based on the databases of the computerized [5] . We search the data on the CONITEC portal -National Commission for the Incorporation of Technologies in SUS [6] . The research was also carried out in the ECRI database -Emergency Care Research Institute [7] . The study used a qualitative approach, starting from an analysis review in official documents of the Secretariat of Science, Technology and Strategic Inputs-SCTIE of the Ministry of Health-MS, related to the IHC and the strategic product lists. The available databases were used to search for market information and competitiveness of the health products industry.
The objective of the study is to consolidate the products in a single list by analyzing the computerized databases and consulting the technical areas of the Ministry of Health, in addition to cross-referencing information with previous publications of priority products. The first phase of the study was to search the National Report of Permanent Equipment and Materials (NRPEM/ RENEM) that can be financed by the Ministry of Health in 2016. We classified the items for diagnosis, therapy, and rehabilitation in this phase of research. We did not consider medical assistance, infrastructure, furniture, mobile units, vehicles, and computers in the study. The items delimited in the research were as following: I Incidence: The aspects were selected based on in the approved quantitative, in which the proposals of investment projects were superior to 500 units in number and with a total value superior to R $ 1,000,000.00. The study returned 16 items with these criteria.
Total Value: The items were selected based on in the approved quantitative, in which the proposals of investment projects were higher than R $ 1,000,000.00 regardless of the amount permitted. The study returned 58 items with these criteria. II Unit Value: Items verified that the maximum allowed values for registration of investment projects were higher than R$ 300,000.00. Returned 36 items in this criterion.
The second phase of the study sought data on incorporation and Judicial Process: Finally, the study considered international data, using the information from the list published in 2017 by the ECRI Institute of 10 medical technologies of most significant risk. This research reviewed the nomenclature and classification available in RENEM and SIGTAP of the Ministry of Health, due to that there is no standardization of item nomenclatures.
Results and Discussion
The study consolidated the data obtained to formulate a single list, and analyzed the items that were repeated in the criteria adopted. The final list was 192 consolidated items, with 20 issues appearing in three principles, described below in the study phases (emphasis on diagnostic imaging equipment, in vitro and in vivo diagnostic analyzers, cardioverter/defibrillator, anesthesia machine, video endoscopy and laparoscopy system, electric scalpel, diagnostic ultrasound, catheter, stents and prosthesis for cochlear implant). In four criteria appeared the multi-parameter monitor and the wheelchair, as well as pulmonary ventilator ( Table  1) .
The study considered all the criteria with the same relevance. [11] . Table 2 presents the list with the cross-referencing of the information found in the publications.
Maldonado and colleagues (2013) present examples of priority equipment necessary to build competencies: i) dedicated chips for the hospital equipment industry, which can be used in numerous electromedical equipment; ii) hemodialysis: filters used in hemodialysis; iii) surgical articles and instruments made from engineering plastics -not by traditional methods of metallurgical industries; iv) automated diagnostic equipment; v) medical imaging: receptors, ultrasound devices, digital radiology; and vi) material technology [2] .
Landim and colleagues (2013) studied four segments of medical devices to detail aspects of the structure and the competitive dynamics of the sector. The selected sections were: in vitro diagnosis, diagnostic imaging, implants and electromedical. The study showed the following opportunities: directing efforts to internalize the assembly of smaller equipment, internalizing technologies for the manufacture of reagents for higher value-added tests, and stimulating the development and production of tests in the country. For imaging equipment, the study indicates that six devices were responsible for about 15% of the entire medical equipment sector deficit in 2012 (Magnetic Resonance Imaging, Ultrasound Imaging, Computed Tomography, Lightning Tubes X, Angiograph and Mammograph). In the implants segment, the study evaluated orthopedic and cardiovascular implants, with emphasis on the development of new materials, such as bioabsorbable and miniaturization of implants with embedded electronics. Finally, electromedical items, with focus on ventilators and vital signs monitors, the study indicates the use of remote monitoring through Information and Communication Technology, as well as the use of bright surgical rooms with integrated systems [12] .
Conclusion
MAE and OPSM identified in this study have been corroborated in previous publications. Of the seventeen items identified as a priority in 2017, twelve were included in the 2008 list of strategic products. This fact shows a concentration of skills needs for these technologies in industrial and technological development, as well as in the technologic services that these products require. The study also presents the peculiar characteristics of the market with a tendency to conglomerates and oligopolies. With recent and intense acquisitions, in particular, in the subsector of diagnosis by imaging and electromedical life support, small and medium-sized national companies focus on the innovation process and competitiveness level in the external market. These changes in the market have a significant impact on the supply and diffusion of these technologies. Several efforts have been made to mitigate technological vulnerability and also to minimize technological assistance gaps. The plan to expand radiotherapy is an example, through the state's purchasing power, not only increased bargaining power in the procurement process but also increased the national productive and technological system through technological compensation.
As a future perspective, technological relevance will be the tools to solve challenges and also strengthen the purchasing power of the State is highlighted. The new Framework for Science, Technology, and Innovation, with Law number 13,243/2016, establishes that "public administration organizations, according to public interested, can directly contract ICT, non-profit private organizations or companies, individually or in consortiums, focused on research activities and recognized technological qualification, aiming to carry out research, development and innovation activities that involve technological risk, in order to solve specific technical problem or obtain product, service or process innovation" [13] . Still pending regulatory aspects, the technological view presents itself as a strategic tool to increase the use of the purchasing power of the State. State purchasing power is crucial to ensure the maximization of available resources and the expansion of health benefits, together with the knowledge of decisions that are required by a universal health system. 
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With the accelerated growth of the health area in Brazil, institutions increasingly seek to optimize the operations by leveraging the results and becoming competitive in the market. Ensuring the high availability of infrastructure and assets provides that the organization is a strategic tool to achieve positive productivity results. However, it is necessary to structure the engineering department of the maintenance and correct administration of the flows that integrate the sector to meet the expected results. The use of computerized maintenance control tools helps in the management of environments and equipment, assuring the operational reliability of the health care establishment. This article presents the stages of implementation of management and maintenance in a health care establishment. The results demonstrate the evolution in the control of the maintenance department with greater efficiency, planning, increased availability of infrastructure and equipment as well as reduced costs for the operation of health sector processes in Brazil. Keywords: Maintenance Management. Assets. Maintenance Software. Availability. Reliability.
Healthcare organizations are seeking alternatives to reduce costs in their operations and optimize production to ensure sustainability with the use of new technologies and the high competitiveness in the market. Some factors affect and interfere in the patient expectations to care to receive according to Establishing Health Outreach (EHO) [1] . For such reasons, EHO needs to be organized to ensure full recovery of the patient's condition. It is essential to provide the operability of the infrastructure and medical equipment to maintain the quality of the provision of services in a healthcare establishment. Intervention management of assets should be carried out correctly and in an organized manner. The maintenance department is essential for ensuring the availability and reliability of equipment and installations. It provides the quality of the final product, making it a strategic sector in a health care setting. This article presents the implementation of a maintenance management program in a healthcare establishment through the application of maintenance management software.
Maintenance Management of Hospital Equipment
Slack and colleagues (2004) [2] classify the following objectives of maintenance: higher product quality, cost reduction, greater safety, better work environment, longer equipment life and, the most important of all, higher reliability of equipment. An effective maintenance management system is one that consists of the elaboration and fulfillment of a maintenance plan. This plan will enable the company to achieve profitability and survival goals with equipment, which not fail nor impair the quality, cost, and delivery of products and services and does not jeopardize the safety and integrity of the environment [3] . The current demands of the area of maintenance of healthy environments should have strategies to improve the safe use of equipment, reduce operating costs and seek guidance in documents from the Ministry of Health [4] . The healthcare environment should be kept in constant operation, adopting best practices and running healthy and environmentally responsible places.
We analyzed the implementation of a maintenance management system, the Smart Clin, software available in health care establishments. The steps of deploying the software involved planning, data collection, and data analysis, implementation of a preventive maintenance plan, training, operation and interpretation of results guided by the PDCA cycle. These steps are a management tool that the goal is to promote continuous improvement of processes using four actions: Plan, Carry out the plan, Check and Act.
Case Report
The present case study was carried out in a leading company for the provision of imaging diagnosis healthcare services, located in the state of Bahia. Maintenance management software was implemented to map, organize and manage the processes of the department. The planning for project development initiated in the second half of 2016 and the analyzed data correspond to 2017. The financial results of the department were compared to evaluate the effectiveness of the project. It is noteworthy that the establishment did not have a defined and organized maintenance department, so the demands were solved as they were identified in the EHO operation routine. There was no control over procedures, cost management and/or application of labor in the maintenance area.
Smartclin Software
TheSmartClinSoftware is a tool for managing services in health units. It consists of several application modules such as supplies, invoicing, human resources and care. Among the modules available, the module "Manut" is for maintenance management and had been inactive in the EHO due to the lack of administration of the department. It is noteworthy that the results of the project were analyzed in the monthly costs of maintenance of building infrastructure and support equipment.
PDCA cycle was used for the implementation of management and software. Figure 1 illustrates the PDCA cycle.
During the planning stage, the following maintenance system objectives were defined: • Control of preventive maintenance of the building; • Control of preventive maintenance of support equipment (refrigeration, air-conditioning, generators, etc.);
• Control of corrective maintenance in equipment and infrastructure; • Define the sector flowchart.
We developed action plans to achieve these objectives through the 5W2H tool. A management tool allowed to organize actions and distribute activities to have a specific result, usually used in a spreadsheet or table format. It consists of 7 questions in English of which 5 start with W and 2 start with H, as follows:
• Why? -Why is it done? • What? -What will be done? • Where? -Where will it be done? • When? -When will it be done? • Who? -Who will it be done? • How? -How will it be done? • How Much? -How much it will be cost?
Managing EHO Maintenance
Macros' tasks were registered for system implementation in the plan of action, as well as the process model and the main activities called flowcharts. The goal of the diagrams (Figures 2 and 3) was to show the team and the department how the maintenance department can meet its internal and external clients with all the steps required to complete a specific task. The flowchart in Figure 2 illustrates the steps of planning, execution, and control of preventive maintenance. The flowchart in Figure 3 illustrates the steps for the opening, conducting and control of corrective maintenance.
System Deployment
After the planning steps, the step of collecting data and parameter settings for structuring the operational database system was initiated. Figure   4 shows the initial screen for the data to access the system.
The infrastructure equipment to be inserted in the system was initially defined, and equipment groups were created to facilitate the identification of assets and their management of the operation. After entering the equipment, setting the criticality of material was also carried out to classify the requests and orders of service according to the degree of importance of the asset before the drive.
The criticality of assets as defined in 4 categories, below: a) Low-active, which does not interfere with the operation of the unit nor the safety of users. b) Medium-active, which can interfere with the operation of the unit, but does not interfere with the protection of users. c) High-active, which interferes directly in the process of the unit, affecting the productive chair, but does not present risks to users. d) Urgent-active, which interferes directly in the production of the unit, and puts users at risk.
After the definition of the groups, the of the imported equipment by equipment for entries in the software such as air conditioning, generators, chillers, no-breaks, etc. Due to the particularities of the system, it was necessary to carry out the registration of physical environments as well as equipment, only in this way was it possible to perform the opening of corrective services requests. For the register of the equipment, the information of the essential features of the asset was considered, such as make, model and serial number. It was used to optimize the time of registration in the field of equipment ensuring deadlines. Figure 5illustrates the equipment registration screen.
For the opening of requests for corrective services, it was necessary to register the types of remedial maintenance services, both for equipment and for infrastructure in general. The definition of corrective service requests allows the measurement of data to help in the decision making based on the data collected. Also in this step, the average times foreseen for the resolution of each service request are indicated. The service request resolution period is also made available to the user during the opening of a service request, allowing them to know instantly when their application will be answered.
During the implementation of the software, the preventive maintenance procedures were also defined, to assist the maintenance team in accomplishing and fulfilling the maintenance plans. The entire maintenance team was involved in meetings and brainstorming tapping the experiences of each team member to collect this data. The procedures were recorded in a spreadsheet and then imported into the system.
System Operation
After the implementation phase, data collection, training and testing the policy went into full operation and became the primary tool for management and maintenance of the EAS. The services department of both corrective maintenance and preventive maintenance began to be managed through the software.
Through a maintenance request, it is possible to perform the control of work orders in the system, such as date, time, equipment, activities to be carried out, the status of orders and services, etc. With the use of the existing filters service orders, groups of equipment, service status, deadlines and a range of information can also be found.
The maintenance teams are requested to perform an activity through a printed document called the service order. With this, the maintenance team can identify the information needed to achieve the operation, such as the applicant, the action that needs to be performed, the location of the equipment and the service sector.
After servicing by a specialized technician, the service is terminated in the system with the upload of the physical document signed by the applicant and the release of all the data recorded by the performer of the service.
Results and Discussion
With the organization, implementation, and operation of this piece of maintenance software, the process of evaluating and managing the data in the system was initiated. With reliable information about easy access, it was possible to carry out the analysis of the data contributing significantly to decision making and the strategic management of maintenance activities.
Among these actions are the acquisition of new equipment, replacement of equipment, needs for works and repairs, logistics of team attendance among others.
The possibility of measuring data with the elaboration of maintenance indicators is essential to accompany the overall performance of the department. Data are stratified at various levels such as units, locations, sectors, and services, facilitating analysis and problem-solving. After a 12-month cycle of maintenance software operation, the primary data of the department were evaluated to analyze the effectiveness of the implementation of the project. The data for the service orders can be seen in Graphic 1.
The amount of preventive maintenance increased, and corrective maintenance fell by almost 50%. A survey was also carried out regarding the costs related to the maintenance department. Graphic 2 illustrates these results.
A significant reduction in department costs can be observed, 46.7% at the end of the year. These data demonstrate the effectiveness of the implementation of a maintenance management system and the applicability of maintenance tools in the health care establishment.
Final Considerations
With the result of the project and the consolidation of the use of the software, it was possible to promote the management of maintenance in the health care establishment. The planning, standardization, and control of the operational routines of the department were consolidated. In this project there was a more significant concern in structuring the maintenance sector initially, adopting simple and satisfactory practices and methods. With the implementation of preventive and corrective maintenance routines, there was an increase in the availability of facilities and equipment, contributing directly and actively to the quality of services provided by the establishment.
After the presentation of the results to the organization's senior management, the maintenance department became a strategic function in the company, joining this new stage to the Department of Clinical Engineering.
The challenge and the next steps will be to improve the use of the software by implementing new strategies and consolidating practices seeking continuous improvement of processes, and the technical capacity of the team involved to ensure the best results for the Maintenance Management and consequently, for the organization and its users.
Mosquito Zero TM
Mosquito Zero is an application that is designed to demonstrate the efficiency and effectiveness of information, education and communication between public authorities and citizens regarding Aedes aegypti, the diseases this mosquito transmits and the health impacts, providing citizens with a smooth and accessible channel of communication about the mosquito and arboviruses through the application and virtual robots.
Using automated point-of-conversation technology (Chatbot for interactivity with the citizen and the city of Salvador, through Facebook, messenger and social network), this is a bot/application that can interact with users of Facebook, Instagram, Tweeter, other applications, and web environments, in an intelligent and humanized way. It responds to and guides users regarding the main problems and related solutions to Aedes aegypti and its pathologies, as well as the information to the public management.
It is an application that has agility and precision, it is fast, friendly and accessible in a technological environment of +1 billion users, with personalized and integrated information of content between public authorities and the user. Mosquito Zero can cross communications and notify the number of users who accessed the bot application; as well as number of user interactions; % of most accessed organizations; % of errors and quizzes (evaluation of user knowledge); number of messages that the bot was unable to interpret; number of users who re-interacted with the bot; number of users who demonstrated satisfaction with the interaction with the bot.
The application has the following functions: The application is currently installed in a totem in the main shopping malls in the city of Salvador, Bahia, Brazil. The proof of concept is now being validated, evaluating the number of interactions between the user and the robot; interacting with children, young and old, low to medium income population. Furthermore, there is an application which is being validated more specifically by young people who interact with the web, mainly in social networks. It is worth emphasizing that the number of interactions between the user and the robot demonstrates the population's interest in learning about mosquito prevention and control measures in homes.
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